Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate versus placebo for bone mineral density after prior bisphosphonate treatment in postmenopausal osteoporosis
2011-000708-17Phase 3Completed
- Sponsor
- Servier
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postmenopausal osteoporosis comparing Strontium ranelate with Placebo (2 arms). Primary endpoint: Lumbar areal bone mineral density. Started Aug 2011; status: completed.
02
Drugs
strontium ranelate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2011-000708-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000708-17.